App-Quantinova.ai

Loss of MGMT promoter methylation and resistance to cisplatin in non-seminomatous germ cell tumors

Catia Moutinho - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

O6-benzylguanine

Prognostic biomarkers as molecular targets for individualized neoadjuvant treatment for cervical cancer

Pablo Moreno-Acosta - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Glycodelin expression in endometrial carcinoma

Hannu Koistinen - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Prognostic significance of CXCL12 protein levels in high-grade serous ovarian carcinoma

Laurence Buisseret - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

CXCL12

Hyaluronan-mediated motility receptor (RHAMM) in ovarian cancer

Stephanie Buttermore - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Hyaluronic acid

Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues

Jeffrey D. Krimmel - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

TP53

Expression of Galectins in high grade serous ovarian cancer

Marilyne Labrie - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

taxane

Identification and characterization of tumor-associated antigens (TAAs) and anti-TAAs autoantibodies as biomarkers in immunodiagnosis of human osteosarcoma by serological proteome analysis

Jitian Li - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Combined analysis of circulating epithelial cell count and serum thyroglobulin for differentiating disease status of the patients with papillary thyroid carcinoma

Ching-Ping Tseng - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The role of Her2 overexpression in Middle Eastern papillary thyroid cancer

Abdul K. Siraj - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

CD44 as a potential therapeutic target and prognosis marker for glioblastoma

Fengfei Wang - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Immunohistochemical multiplex staining strategies with CD8, CD103, PD-1, FOXP3 and pan melanoma cocktail in tumor infiltrating lymphocytes in melanoma

David E. Tacha - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

A digital sorting-based detection and isolation assay for single disseminated cancer cells from lymph nodes of melanoma patients

Sebastian Scheitler - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

GP100

NTF2 regulates nuclear size in mammalian cells and may contribute to altered nuclear size in melanoma

Lidija D. Vukovic - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Detection and clinical significance of circulating tumor cells in squamous cell carcinoma of the head and neck

Kazuaki Chikamatsu - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Low-molecular-mass secretome profiling identifies prognostic biomarkers for oral cavity squamous cell carcinomas

Kai-Ping Chang - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Atypical expression of V-tubulin in secretory cells of the fallopian tube as a biomarker for early dysplasia

Deepti Mathew - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Pre-treatment platelet counts as a prognostic factor in stage II and III rectal adenocarcinoma

Ioannis Voutsadakis - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Blood-based profiling of patients with NSCLC using CLIA certified cell-free DNA tests for EGFR, KRAS and BRAF point mutations and test use in clinical practice

Hestia Mellert - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Usefulness of exosome quantification by cholesteryl ester transfer protein activity as a biomarker for human esophageal squamous cell carcinoma (ESCC)

Yasunori Matsumoto - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Filters

41730 Abstracts